Human Factors Studies for Injectable Combination Products: From Planning to Reporting

References

1. 1.↵
   FDA. Design Control Guidance for Medical Device Manufacturers, March 11, 1997.
2. 2.↵
   1. Weinger M. B.,
   2. Wiklund M. E.,
   3. Gardner-Bonneau D. J.

   Handbook of Human Factors in Medical Device Design; CRC Press: Boca Raton, FL, 2011.
3. 3.↵
   ISO/IEC 62366:2007, Medical devices—Application of usability engineering to medical devices. Geneva, International Electrotechnical Commission.
4. 4.↵
   AAMI/ANSI HE75:2009, Human Factors Engineering—Design of Medical Devices.
5. 5.↵
   AAMI/ANSI/ISO 14971:2012, Medical Devices—Application of risk management to medical devices. International Organization for Standardization: Geneva, Switzerland.
6. 6.↵
   ISO/IEC 60601-1-8:2006, Medical electrical equipment—Part 1-8: General requirements for basic safety and essential performance—Collateral Standard: General requirements, tests and guidance for alarm systems in medical electrical equipment and medical electrical systems. International Electrotechnical Commission: Geneva, Switzerland.
7. 7.↵
   AAMI/ANSI HE74:2001/(R)2009, Human Factors Design Process for Medical Devices.
8. 8.
   FDA Guidance for Industry and FDA Premarket and Design Control Reviewers Medical Device Use-Safety: Incorporating Human Factors Engineering into Risk Management. July 2000.
9. 9.↵
   FDA Draft Guidance for Industry and FDA Staff, Applying Human Factors and Usability Engineering to Optimize Medical Device Design. June 2011.
10. 10.
    FDA Draft Guidance for Industry and FDA Staff: Design Considerations for Devices Intended for Home Use. December 2012.
11. 11.
    FDA Draft Guidance for Industry: Safety Considerations for Product Design to Minimize Medication Errors. December 2012.
12. 12.
    FDA Draft Guidance for Industry and FDA Staff: Submissions for Post-approval Modifications to a Combination Product Approved Under a BLA, NDA, or PMA. January 2013.
13. 13.↵
    FDA Draft Guidance for Industry: Safety Considerations for Container Labels and Carton Labeling Design To Minimize Medication Errors. April 2013.
14. 14.
    FDA Draft Guidance for Industry and FDA Staff: Glass Syringes for Delivering Drug and Biological Products: Technical Information To Supplement International Organization for Standardization (ISO) Standard 11040-4. April 2013.
15. 15.↵
    FDA Draft Guidance for Industry, Rheumatoid Arthritis: Developing Drug Products for Treatment. May 2013.
16. 16.
    FDA Guidance for Industry and FDA Staff: Technical Considerations for Pen, Jet, and Related Injectors Intended for Use with Drugs and Biological Products. June 2013.
17. 17.↵
    1. Faulkner L.

    Beyond the five-user assumption: benefits of increased sample sizes in usability testing. Behavior Research Methods, Instruments, and Computers 2003, 35 (3), 379–383.

    OpenUrlCrossRefPubMed
18. 18.↵
    Master Files: Introduction to Master Files for Devices (MAFs), FDA CDRH Website, www.fda.gov/MedicalDevices/DeviceRegulationsandGuidance.
19. 19.↵
    FDA Guidance on Medical Device Patient Labeling; Final Guidance for Industry and FDA Reviewers. April 2001.
20. 20.↵
    Wyeth vs Levine, 555 U.S. 555, Supreme Court of United States, Decision: March 4, 2009.
21. 21.↵
    FDA Guidance. Deciding When to Submit a 510(k) for a Change to an Existing Device, January 4, 1997.